Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-08-26 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
募集资金使用管理制度（2021年8月修订）
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金使用管理制度' which translates to 'Fundraising Capital Usage Management System' and is a detailed internal policy document regarding the management, usage, and supervision of funds raised by the company. It references regulatory frameworks such as the Company Law, Securities Law, Shanghai Stock Exchange Listing Rules, and includes detailed procedural rules for managing raised funds, investment plans, supervision, and reporting requirements. The document is not a financial report, earnings release, or announcement but rather a governance and compliance policy document related to capital management. It does not contain financial statements or results but sets out the rules and procedures for managing capital raised by the company. Therefore, it fits best under the category of Capital/Financing Update (CAP) as it deals with the management and use of capital raised by the company.
2021-08-26 Chinese
对外担保管理制度（2021年8月修订）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is a detailed internal policy document approved by the company's board of directors. It outlines the rules, procedures, responsibilities, and disclosure requirements related to the company's external guarantees. There is no indication that this is a financial report, audit report, earnings release, or any form of regulatory filing. It is a governance-related document detailing internal rules and management practices regarding external guarantees. Therefore, it fits best under Governance Information (CGR). The document length (6231 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2021-08-26 Chinese
董事会议事规则（2021年8月修订）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors' of 益丰大药房连锁股份有限公司. It details the governance structure, duties, meeting procedures, and responsibilities of the board and independent directors. There is no financial data, no mention of financial results, no audit reports, no voting results, no announcements of report publications, or any other regulatory filings. The content is focused on internal governance rules and board management practices. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (9928 characters), indicating it is a full governance report rather than a brief announcement or notice.
2021-08-26 Chinese
股东大会议事规则（2021年8月修订）
Governance Information Classification · 95% confidence The document is titled as "益丰大药房连锁股份有限公司 股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting". It contains detailed procedural rules for convening, conducting, and voting at shareholders' meetings, including rights and responsibilities of shareholders, board, and other parties. It references legal frameworks and company bylaws but does not contain financial statements, audit results, or report data. It is a governance document outlining internal rules and procedures related to shareholder meetings rather than an announcement, report, or transcript. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance content, supporting high confidence in classification.
2021-08-26 Chinese
益丰药房第四届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Yifeng Pharmacy Chain Co., Ltd. It details the meeting held on August 26, 2021, including the approval of the 2021 semi-annual report and related matters such as the use of raised funds and credit applications. The document is a formal announcement of the meeting's decisions and approvals rather than the semi-annual report itself. It contains no actual financial statements or detailed financial data but confirms the approval of the semi-annual report and other proposals. Given the nature and length (1455 characters), it is an announcement of meeting resolutions rather than the report itself or a detailed interim report. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about supervisory board meeting resolutions and approvals.
2021-08-26 Chinese
益丰药房2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2021 年半年度报告" which translates to "2021 Semi-Annual Report". It contains detailed financial data, management discussion and analysis, company overview, business operations, and financial indicators for the first half of the year 2021 (January 1 to June 30). The document is lengthy (15,000 characters) and includes comprehensive financial statements and analysis, not just an announcement or summary. The presence of detailed financial data and management discussion confirms it is an Interim / Quarterly Report rather than a brief earnings release or an announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-26 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.